KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Incyte (INCY) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to -$3.6 billion.

  • Incyte's Enterprise Value fell 6591.53% to -$3.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$3.6 billion, marking a year-over-year decrease of 6591.53%. This contributed to the annual value of -$3.6 billion for FY2025, which is 6591.53% down from last year.
  • Latest data reveals that Incyte reported Enterprise Value of -$3.6 billion as of Q4 2025, which was down 6591.53% from -$2.9 billion recorded in Q3 2025.
  • Incyte's 5-year Enterprise Value high stood at -$1.4 billion for Q2 2024, and its period low was -$3.9 billion during Q1 2024.
  • Its 5-year average for Enterprise Value is -$2.7 billion, with a median of -$2.6 billion in 2022.
  • Its Enterprise Value has fluctuated over the past 5 years, first surged by 5765.86% in 2024, then plummeted by 6707.4% in 2025.
  • Incyte's Enterprise Value (Quarter) stood at -$2.3 billion in 2021, then tumbled by 37.93% to -$3.2 billion in 2022, then dropped by 12.88% to -$3.7 billion in 2023, then soared by 40.97% to -$2.2 billion in 2024, then plummeted by 65.92% to -$3.6 billion in 2025.
  • Its Enterprise Value was -$3.6 billion in Q4 2025, compared to -$2.9 billion in Q3 2025 and -$2.4 billion in Q2 2025.